NCT05939284View on ClinicalTrials.gov

Progesterone-Primed Ovarian Simulation in Controlled-ovarian Simulation of Infertile PCOS Patients

NACompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

September 14, 2022

Study Completion Date

January 25, 2023

Conditions
PCOS
Interventions
DRUG

Injection of Cetrorelix

Patients received Cetrorelix subcutaneous injection on the day-6 in a dose of 0.25 daily till the trigger day.

DRUG

Oral insertion of dydrogeserone

Patients received dydrogesterone in an oral dose of 20 mg/day in parallel with gonadotropin injection from day-2 of the menstrual cycle till the trigger day

Trial Locations (1)

44519

Zagazig university, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV